Meet Genevolve Vision Diagnostics
This is the first article in a continuing monthly series that will chronicle the growth path of Genevolve Vision Diagnostics, a life sciences startup based in Albuquerque, NM that is commercializing cutting edge genetic research to develop new diagnostic tests and gene therapies for colour blindness.
By Francis Moran and Leo Valiquette
When a startup’s underlying intellectual property has already been hailed by Time Magazine as one of the year’s top 10 scientific discoveries, it may foster the perception that the road to commercial success is already assured. But president and CEO Matt Lemelin and the team at Genevolve Vision Diagnostics have learned that a great discovery is only the beginning of a long and challenging journey.
“We are creating a new market with an advanced technology that many said was not possible,” Lemelin said. “We’ve been labeled as pioneers, a term that concerns me ever since I heard a seasoned veteran state ‘pioneers get slaughtered, settlers prosper.’”
